Emerging new targets in ovarian cancer

被引：0
|
作者：
Kaye, S. [1 ]
机构：
[1] Royal Marsden Hosp, Sutton, Surrey, England
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)70174-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：50 / 50
页数：1
相关论文
共 50 条
  • [21] Emerging drugs for ovarian cancer
    Lorusso, Domenica
    Pietragalla, Antonella
    Mainenti, Sara
    Di Legge, Alessia
    Amadio, Giulia
    Scambia, Giovanni
    EXPERT OPINION ON EMERGING DRUGS, 2010, 15 (04) : 635 - 652
  • [22] The emerging role of JAK inhibitors in ovarian cancer: new kids on the block?
    Al-Bataineh, Rania
    Al Sharie, Ahmed H.
    Altal, Omar F.
    ANNALS OF MEDICINE AND SURGERY, 2024, 86 (02): : 631 - 634
  • [23] Emerging Metabolic Targets in Cancer Therapy
    Zhao, Yuhua
    Liu, Hao
    Riker, Adam I.
    Fodstad, Oystein
    Ledoux, Susan P.
    Wilson, Glenn L.
    Tan, Ming
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2011, 16 : 1844 - 1860
  • [24] EMERGING DRUGGABLE TARGETS IN COLORECTAL CANCER
    Di Nicolantonio, F.
    ANNALS OF ONCOLOGY, 2014, 25
  • [25] Emerging targets in cancer drug resistance
    Kumar, Shashank
    Kushwaha, Prem Prakash
    Gupta, Sanjay
    CANCER DRUG RESISTANCE, 2019, 2 (02) : 161 - 177
  • [26] Emerging Targets of Immunotherapy in Gynecologic Cancer
    Cheng, Hongyan
    Zong, Liju
    Kong, Yujia
    Gu, Yu
    Yang, Junjun
    Xiang, Yang
    ONCOTARGETS AND THERAPY, 2020, 13 : 11869 - 11882
  • [27] EMERGING MOLECULAR TARGETS IN GYNAECOLOGICAL CANCER
    Huntsman, D.
    ANNALS OF ONCOLOGY, 2014, 25
  • [28] Emerging immunotherapy targets in lung cancer
    Zhu Hao-Hua
    Feng Yu
    Hu Xing-Sheng
    中华医学杂志英文版, 2020, 133 (20) : 2456 - 2465
  • [29] Cancer Therapeutics: Emerging Targets and Trends
    Ullah, Mohd. Fahad
    CURRENT CANCER THERAPY REVIEWS, 2008, 4 (01) : 50 - 56
  • [30] Emerging therapeutic targets in bladder cancer
    Carneiro, Benedito A.
    Meeks, Joshua J.
    Kuzel, Timothy M.
    Scaranti, Mariana
    Abdulkadir, Sarki A.
    Giles, Francis J.
    CANCER TREATMENT REVIEWS, 2015, 41 (02) : 170 - 178
12345